JERUSALEM--(BUSINESS WIRE)--BioLineRx Ltd. (TASE:BLRX), Israel’s leading drug development company, today announced that it has signed worldwide exclusive license agreements with PolyGene Ltd. and Efrat BioPolymers Ltd. for the development and commercialization of their proprietary polymer drug delivery system designed to improve the efficacy, safety and ease of administration of a variety of drugs. Financial terms of the license were not disclosed.
